Hashemi M, Khoushab S, Hobabi Aghmiuni M, Anaraki S, Alimohammadi M, Taheriazam A
Heliyon. 2024; 10(21):e40096.
PMID: 39583806
PMC: 11582460.
DOI: 10.1016/j.heliyon.2024.e40096.
Hu K, Xie L, Wu W, Zhang J, Li Y, He J
Int J Biol Sci. 2024; 20(8):3140-3155.
PMID: 38904029
PMC: 11186368.
DOI: 10.7150/ijbs.93335.
Kubat Oktem E
J Mol Neurosci. 2024; 74(2):51.
PMID: 38700745
DOI: 10.1007/s12031-024-02228-0.
Bellah S, Xiong F, Dou Z, Yang F, Liu X, Yao X
J Mol Cell Biol. 2024; 16(2).
PMID: 38402459
PMC: 11328731.
DOI: 10.1093/jmcb/mjae008.
Tuly K, Hossen M, Islam M, Kibria M, Alam M, Harun-Or-Roshid M
Medicina (Kaunas). 2023; 59(10).
PMID: 37893423
PMC: 10608013.
DOI: 10.3390/medicina59101705.
Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma.
Wang R, Wang D, Bai X, Guo J, Xia S, Cheng Y
Cell Death Discov. 2023; 9(1):231.
PMID: 37419907
PMC: 10328921.
DOI: 10.1038/s41420-023-01526-7.
Therapeutic Effectiveness of Anticancer Agents Targeting Different Signaling Molecules Involved in Asymmetric Division of Cancer Stem Cell.
Samanta P, Bhowmik A, Biswas S, Sarkar R, Ghosh R, Pakhira S
Stem Cell Rev Rep. 2023; 19(5):1283-1306.
PMID: 36952080
DOI: 10.1007/s12015-023-10523-3.
Myotubularin-Related Protein14 Prevents Neointima Formation and Vascular Smooth Muscle Cell Proliferation by Inhibiting Polo-Like Kinase1.
Kong L, Liang C, Li P, Zhang Y, Feng S, Zhang D
J Am Heart Assoc. 2022; 11(21):e026174.
PMID: 36314496
PMC: 9673629.
DOI: 10.1161/JAHA.122.026174.
DNA damage checkpoint execution and the rules of its disengagement.
Yam C, Lim H, Surana U
Front Cell Dev Biol. 2022; 10:1020643.
PMID: 36274841
PMC: 9582513.
DOI: 10.3389/fcell.2022.1020643.
Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities.
Lee C, Kim J
Oncol Lett. 2022; 23(6):192.
PMID: 35527780
PMC: 9073582.
DOI: 10.3892/ol.2022.13312.
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
Hagege A, Ambrosetti D, Boyer J, Bozec A, Doyen J, Chamorey E
Theranostics. 2021; 11(19):9571-9586.
PMID: 34646387
PMC: 8490521.
DOI: 10.7150/thno.61711.
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer.
Yang Z, Liang S, Saliakoura M, Yang H, Vassella E, Konstantinidou G
EMBO Mol Med. 2021; 13(9):e13193.
PMID: 34369083
PMC: 8422071.
DOI: 10.15252/emmm.202013193.
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.
Chan K, Abdul-Sater Z, Sheth A, Mitchell D, Sharma R, Edwards D
Mol Oncol. 2021; 16(4):860-884.
PMID: 34058059
PMC: 8847993.
DOI: 10.1002/1878-0261.13027.
Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma.
Ma H, Nie C, Chen Y, Li J, Xie Y, Tang Z
Oncol Res. 2021; 28(7):745-761.
PMID: 33573708
PMC: 8420894.
DOI: 10.3727/096504021X16130322409507.
STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C
Theranostics. 2021; 11(5):2108-2122.
PMID: 33500714
PMC: 7797677.
DOI: 10.7150/thno.48112.
(Bora), Which Promotes Plk1 Activation by Aurora A, Has an Oncogenic Role in Ovarian Cancer.
Parrilla A, Barber M, Majem B, Castellvi J, Morote J, Sanchez J
Cancers (Basel). 2020; 12(4).
PMID: 32268485
PMC: 7226261.
DOI: 10.3390/cancers12040886.
Cytokinesis in Eukaryotic Cells: The Furrow Complexity at a Glance.
Fraschini R
Cells. 2020; 9(2).
PMID: 31979090
PMC: 7072619.
DOI: 10.3390/cells9020271.
Methylation of PLK1 by SET7/9 ensures accurate kinetochore-microtubule dynamics.
Yu R, Wu H, Ismail H, Du S, Cao J, Wang J
J Mol Cell Biol. 2019; 12(6):462-476.
PMID: 31863092
PMC: 7333475.
DOI: 10.1093/jmcb/mjz107.
A requirement of Polo-like kinase 1 in murine embryonic myogenesis and adult muscle regeneration.
Jia Z, Nie Y, Yue F, Kong Y, Gu L, Gavin T
Elife. 2019; 8.
PMID: 31393265
PMC: 6687435.
DOI: 10.7554/eLife.47097.
A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair.
Li W, Wang H, Zhao X, Duan H, Cheng B, Liu Y
Sci Adv. 2019; 5(3):eaau7566.
PMID: 30854428
PMC: 6402851.
DOI: 10.1126/sciadv.aau7566.